A trial to learn how safe AZD9550 is in people with or without type 2 diabetes who are overweight or obese

Trial Identifier: D8460C00002
Sponsor: AstraZeneca
Start Date: September 2023
Primary Completion Date: July 2026
Study Completion Date: July 2026
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AT Graz, AT, 8036
AT Vienna, AT, 1090
CA, BC Surrey, BC, CA, V3T 2V6
CA, ON Sarnia, ON, CA, N7T 4X3
CA, ON Stouffville, ON, CA, L4A 1H2
CA, ON Toronto, ON, CA, M4G 3E8
CA, Ontario Toronto, Ontario, CA, M4J 5B9
CA, QC Sherbrooke, QC, CA, J1L 0H8
DE Magdeburg, DE, 39120
DE Neuss, DE, 41460
DE Neu-Ulm, DE, 89231
JP Fukuoka-shi, JP, 812-0025
JP Shinjuku-ku, JP, 160-0004
JP Suita-shi, JP, 565-0853
SE Uppsala, SE, 752 37